Product Name:Lorlatinib(PF0643922)
Formulae hypotheticae: C21H19FN6O2
M. Pondus: 406.41
CAS Subcriptio Number; 1454846-35-5
Lorlatinib(PF0643922)
Product nomen:Lorlatinib(PF0643922) 1454846-35-5
Nomen
Lorlatinib(PF0643922)
Synonyma
PF0643922; PF-06463922;(10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4; 3-h][2,5,11] benzoxadiazacyclotetradecine-3-carbonitrile;Lorlatinib,PF-Chemica albook06463922; PF-06463922, Lorlatinib;(R)-26-amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina. -1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile;EOS 60936; Loratinib
M. Structure
Formulae hypotheticae
C21H19FN6O2
M. Pondus
406.41
CAS Subcriptio Number
1454846-35-5
Tractantem et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.
Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum